The RhoGAP domain-containing protein, Porf-2, inhibits proliferation and enhances apoptosis in neural stem cells

Molecular and Cellular Neuroscience

Volumn 46, Issue 3, 2011, Pages 573-582

  Ma, Shuang ^a   Nowak, Felicia V ^a  

^a OHIO UNIVERSITY   (United States)

Author keywords

Apoptosis; Bax; Cell cycle; Neural stem cell; P21; P53; Preoptic regulatory factor 2; Proliferation; RhoGAP domain containing protein

Indexed keywords

BLEOMYCIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; PREOPTIC REGULATORY FACTOR 2; PROTEIN BAX; PROTEIN P21; PROTEIN P53; RHO FACTOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; STAUROSPORINE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL LINE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CEREBELLUM; CONTROLLED STUDY; GENE SILENCING; MOUSE; MULTIPOTENT STEM CELL; NEURAL STEM CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ENZYME INHIBITORS; GENE KNOCKDOWN TECHNIQUES; GONADOTROPIN-RELEASING HORMONE; GTPASE-ACTIVATING PROTEINS; MICE; NEURAL STEM CELLS; STAUROSPORINE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79951855113     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2010.12.008     Document Type: Article

References (56)

1. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998, 281(5381):1322-1326.
2. Amundson S.A., Myers T.G., Fornace A.J. Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogene 1998, 17(25):3287-3299.
3. Aznar S., Lacal J.C. Rho signals to cell growth and apoptosis. Cancer Lett. 2001, 165(1):1-10.
4. Butt A.J., Firth S.M., King M.A., Baxter R.C. Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells. J. Biol. Chem. 2000, 275(50):39174-39181.
5. Cayre M., Malaterre J., Scotto-Lomassese S., Strambi C., Strambi A. The common properties of neurogenesis in the adult brain: from invertebrates to vertebrates. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2002, 132(1):1-15.
6. Ceccatelli S., Tamm C., Sleeper E., Orrenius S. Neural stem cells and cell death. Toxicol. Lett. 2004, 149(1-3):59-66.
7. Ching Y.P., Wong C.M., Chan S.F., Leung T.H., Ng D.C., Jin D.Y., Ng I.O. Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma. J. Biol. Chem. 2003, 278(12):10824-10830.
8. Clarke M.F. Neurobiology: at the root of brain cancer. Nature 2004, 432(7015):281-282.
9. Costello P.S., Cleverley S.C., Galandrini R., Henning S.W., Cantrell D.A. The GTPase rho controls a p53-dependent survival checkpoint during thymopoiesis. J. Exp. Med. 2000, 192(1):77-85.
10. Daniela F., Vescovi A.L., Bottai D. The stem cells as a potential treatment for neurodegeneration. Meth. Mol. Biol. 2007, 399:199-213.
11. El-Deiry W.S., Harper J.W., O'Connor P.M., Velculescu V.E., Canman C.E., Jackman J., Pietenpol J.A. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 1994, 54(5):1169-1174.
12. Etienne-Manneville S., Hall A. Rho GTPases in cell biology. Nature 2002, 420(6916):629-635.
13. Evers E.E., van der Kammen R.A., ten Klooster J.P., Collard J.G. Rho-like GTPases in tumor cell invasion. Meth. Enzymol. 2000, 325:403-415.
14. Forger N.G. Control of cell number in the sexually dimorphic brain and spinal cord. J. Neuroendocrinol. 2009, 21:393-399.
15. Frame M.C., Brunton V.G. Advances in Rho-dependent actin regulation and oncogenic transformation. Curr. Opin. Genet. Dev. 2002, 12(1):36-43.
16. Geng Y., Akhtar R.S., Shacka J.J., Klocke B.J., Zhang J., Chen X., Roth K.A. p53 transcription-dependent and -independent regulation of cerebellar neural precursor cell apoptosis. J. Neuropathol. Exp. Neurol. 2007, 66(1):66-74.
17. Geng Y., Walls K.C., Ghosh A.P., Akhtar R.S., Klocke B.J., Roth K.A. Cytoplasmic p53 and activated Bax regulate p53-dependent, transcription-independent neural precursor cell apoptosis. J. Histochem. Cytochem. 2010, 58(3):265-275.
18. Grote H.E., Hannan A.J. Regulators of adult neurogenesis in the healthy and diseased brain. Clin. Exp. Pharmacol. Physiol. 2007, 34(5-6):533-545.
19. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993, 75(4):805-816.
20. Jin S., Levine A.J. The p53 functional circuit. J. Cell Sci. 2001, 114(Pt 23):4139-4140.
21. Johnson T.S., O'Neill A.C., Motarjem P.M., Nazzal J., Randolph M., Winograd J.M. Tumor formation following murine neural precursor cell transplantation in a rat peripheral nerve injury model. J. Reconstr. Microsurg. 2008, 24(8):545-550.
22. Joseph B., Hermanson O. Molecular control of brain size: regulators of neural stem cell life, death and beyond. Exp. Cell Res. 2010, 316(8):1415-1421.
23. Kokovay E., Shen Q., Temple S. The incredible elastic brain: how neural stem cells expand our minds. Neuron 2008, 60(3):420-429.
24. Kriegstein A., Alvarez-Buylla A. The glial nature of embryonic and adult neural stem cells. Annu. Rev. Neurosci. 2009, 32:149-184.
25. Kriegstein A., Noctor S., Martinez-Cerdeño V. Patterns of neural stem and progenitor cell division may underlie evolutionary cortical expansion. Nat. Rev. Neurosci. 2006, 7(11):883-890.
26. Macleod K.F., Sherry N., Hannon G., Beach D., Tokino T., Kinzler K., Vogelstein B., Jacks T. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 1995, 9(8):935-944.
27. Mettouchi A., Klein S., Guo W., Lopez-Lago M., Lemichez E., Westwick J.K., Giancotti F.G. Integrin-specific activation of Rac controls progression through the G(1) phase of the cell cycle. Mol. Cell 2001, 8(1):115-127.
28. Mitchell K.O., Ricci M.S., Miyashita T., Dicker D.T., Jin Z., Reed J.C., El-Deiry W.S. Bax is a transcriptional target and mediator of c-myc-induced apoptosis. Cancer Res. 2000, 60(22):6318-6325.
29. Miyashita T., Kitada S., Krajewski S., Horne W.A., Delia D., Reed J.C. Overexpression of the Bcl-2 protein increases the half-life of p21Bax. J. Biol. Chem. 1995, 270(44):26049-26052.
30. Modarressi M.H., Cheng M., Tarnasky H.A., Lamarche-Vane N., de Rooij D.G., Ruan Y., van der Hoorn F.A. A novel testicular RhoGAP-domain protein induces apoptosis. Biol. Reprod. 2004, 71(6):1980-1990.
31. Nagaraja G.M., Kandpal R.P. Chromosome 13q12 encoded Rho GTPase activating protein suppresses growth of breast carcinoma cells, and yeast two-hybrid screen shows its interaction with several proteins. Biochem. Biophys. Res. Commun. 2004, 313(3):654-665.
32. Nandoe Tewarie R.S., Hurtado A., Bartels R.H., Grotenhuis A., Oudega M. Stem cell-based therapies for spinal cord injury. J. Spinal Cord Med. 2009, 32(2):105-114.
33. Nowak F.V. Expression and characterization of the preoptic regulatory factor-1 and -2 peptides. Regul. Pept. 2003, 115(3):179-185.
34. Nowak F.V., Gilham S.C. Growth factor effects of PORF-2. Proceedings of the Annual Meeting of the Society for Neuroscience, San Diego, CA 2004, abst.
35. Nowak F.V., Gore A.C. Perinatal developmental changes in expression of the neuropeptide genes preoptic regulatory factor-1 and factor-2, neuropeptide Y and GnRH in rat hypothalamus. J. Neuroendocrinol. 1999, 11(12):951-958.
36. Nowak F.V., Torres G.E., Hu S.B. Differential gene expression response to gonadal hormones by preoptic regulatory factors-1 and -2 in the female rat brain. Neuroendocrinology 1999, 69(3):191-201.
37. Olson M.F., Ashworth A., Hall A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 1995, 269(5228):1270-1272.
38. Olson M.F., Paterson H.F., Marshall C.J. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature 1998, 394(6690):295-299.
39. Oppenheim R.W. Cell death during development of the nervous system. Annu. Rev. Neurosci. 1991, 14:453-501.
40. Ourednik J., Ourednik V., Lynch W.P., Schachner M., Snyder E.Y. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat. Biotechnol. 2002, 20(11):1103-1110.
41. Peck J., Douglas G., Wu C.H., Burbelo P.D. Human RhoGAP domain-containing proteins: structure, function and evolutionary relationships. FEBS Lett. 2002, 528(1-3):27-34.
42. Pervaiz S., Cao J., Chao O.S., Chin Y.Y., Clement M.V. Activation of the RacGTPase inhibits apoptosis in human tumor cells. Oncogene 2001, 20(43):6263-6268.
43. Rudolph C., Adam G., Simm A. Determination of copy number of c-Myc protein per cell by quantitative Western blotting. Anal. Biochem. 1999, 269(1):66-71.
44. Ryder E.F., Snyder E.Y., Cepko C.L. Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer. J. Neurobiol. 1990, 21(2):356-375.
45. Salomoni P., Calegari F. Cell cycle control of mammalian neural stem cells: putting a speed limit on G1. Trends Cell Biol. 2010, 20(5):233-243.
46. Sharp J., Keirstead H.S. Stem cell-based cell replacement strategies for the central nervous system. Neurosci. Lett. 2009, 456(3):107-111.
47. Sillitoe R.V., Joyner A.L. Morphology, molecular codes, and circuitry produce the three-dimensional complexity of the cerebellum. Annu. Rev. Cell Dev. Biol. 2007, 23:549-577.
48. Snyder E.Y., Daley G.Q., Goodell M. Taking stock and planning for the next decade: realistic prospects for stem cell therapies for the nervous system. J. Neurosci. Res. 2004, 76(2):157-168.
49. Tcherkezian J., Lamarche-Vane N. Current knowledge of the large RhoGAP family of proteins. Biol. Cell 2007, 99(2):67-86.
50. Teng Y.D., Lavik E.B., Qu X., Park K.I., Ourednik J., Zurakowski D., et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc. Natl Acad. Sci. USA 2002, 99(5):3024-3029.
51. Welsh C.F., Roovers K., Villanueva J., Liu Y., Schwartz M.A., Assoian R.K. Timing of cyclin D1 expression within G1 phase is controlled by Rho. Nat. Cell Biol. 2001, 3(11):950-957.
52. Yadirgi G., Marino S. Adult neural stem cells and their role in brain pathology. J. Pathol. 2009, 217(2):242-253.
53. Yang F.C., Kapur R., King A.J., Tao W., Kim C., Borneo J., Breese R., et al. Rac2 stimulates Akt activation affecting BAD/Bcl-XL expression while mediating survival and actin function in primary mast cells. Immunity 2000, 12(5):557-568.
54. Zaidi H.A., Kosztowski T., DiMeco F., Quinones-Hinojosa A. Origins and clinical implications of the brain tumor stem cell hypothesis. J. Neurooncol. 2009, 93(1):49-60.
55. Zhang B.F., Peng F.F., Zhang J.Z., Wu D.C. Staurosporine induces apoptosis in NG108-15 cells. Acta Pharmacol. Sin. 2003, 24(7):663-669.
56. Zhang X.D., Gillespie S.K., Hersey P. Staurosporine induces apoptosis of melanoma by both caspase-dependent and -independent apoptotic pathways. Mol. Cancer Ther. 2004, 3(2):187-197.